99 related articles for article (PubMed ID: 9761119)
1. Quantitative analysis of p53 protein in non-small cell lung cancer and its prognostic value.
Levesque MA; D'Costa M; Spratt EH; Yaman MM; Diamandis EP
Int J Cancer; 1998 Oct; 79(5):494-501. PubMed ID: 9761119
[TBL] [Abstract][Full Text] [Related]
2. p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis.
Pappot H; Francis D; Brünner N; Grondahl-Hansen J; Osterlind K
Clin Cancer Res; 1996 Jan; 2(1):155-60. PubMed ID: 9816102
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.
Nishio M; Koshikawa T; Kuroishi T; Suyama M; Uchida K; Takagi Y; Washimi O; Sugiura T; Ariyoshi Y; Takahashi T; Ueda R; Takahashi T
J Clin Oncol; 1996 Feb; 14(2):497-502. PubMed ID: 8636763
[TBL] [Abstract][Full Text] [Related]
4. p21WAF1 protein expression determined by quantitative immunoassay in relation to non-small-cell lung cancer aggressiveness.
Levesque MA; D'Costa M; Diamandis EP
J Cancer Res Clin Oncol; 2000 Jan; 126(1):48-52. PubMed ID: 10641749
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
8. p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival.
Caputi M; Esposito V; Baldi A; De Luca A; Dean C; Signoriello G; Baldi F; Giordano A
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):213-7. PubMed ID: 9476908
[TBL] [Abstract][Full Text] [Related]
9. The relationship of p53 immunostaining to survival in carcinoma of the lung.
McLaren R; Kuzu I; Dunnill M; Harris A; Lane D; Gatter KC
Br J Cancer; 1992 Oct; 66(4):735-8. PubMed ID: 1329907
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance and prognostic role of EZH2 expression in non-small cell lung cancer.
Kim NY; Pyo JS
Pathol Res Pract; 2017 Jul; 213(7):778-782. PubMed ID: 28554757
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer.
Rybárová S; Hodorová I; Muri J; Mihalik J; Adamkov M; Svajdler M; Piovarci D; Mirossay L
Tumori; 2011; 97(1):79-85. PubMed ID: 21528669
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
Rades D; Setter C; Dahl O; Schild SE; Noack F
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
[TBL] [Abstract][Full Text] [Related]
13. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
Ebina M; Steinberg SM; Mulshine JL; Linnoila RI
Cancer Res; 1994 May; 54(9):2496-503. PubMed ID: 7909277
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.
Lee JS; Yoon A; Kalapurakal SK; Ro JY; Lee JJ; Tu N; Hittelman WN; Hong WK
J Clin Oncol; 1995 Aug; 13(8):1893-903. PubMed ID: 7636531
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.
Yuan A; Yang PC; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT
Am J Respir Crit Care Med; 2000 Nov; 162(5):1957-63. PubMed ID: 11069840
[TBL] [Abstract][Full Text] [Related]
17. Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis.
Xu HJ; Cagle PT; Hu SX; Li J; Benedict WF
Clin Cancer Res; 1996 Jul; 2(7):1169-76. PubMed ID: 9816284
[TBL] [Abstract][Full Text] [Related]
18. A study of smoking, p53 tumor suppressor gene alterations and non-small cell lung cancer.
Tammemagi MC; McLaughlin JR; Mullen JB; Bull SB; Johnston MR; Tsao MS; Casson AG
Ann Epidemiol; 2000 Apr; 10(3):176-85. PubMed ID: 10813511
[TBL] [Abstract][Full Text] [Related]
19. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
20. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
Korkolopoulou P; Oates J; Crocker J; Edwards C
J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]